For whom the bell tolls: isoniazid preventive therapy and tuberculosis drug resistance.
The expected increase in drug-resistant tuberculosis due to large-scale preventive treatment in people living with HIV calls for reconsidering the "double use" of isoniazid for prophylaxis and curative treatment (Mills et al., this issue).